12 Dec 2019 - The Board of GrainCorp (ASX:GNC) has appointed Robert Spurway as Managing Director and CEO after completion of the planned demerger of the Company’s Malt business in early 2020.
12 Dec 2019 - Senex Energy (ASX:SXY) today announced an expansion of its natural gas sales agreement with leading manufacturer Orora (ASX:ORA), agreeing to supply 13.2 petajoules of natural gas from Project Atlas.
11 Dec 2019 - Following a lacklustre day yesterday from the US markets, the ASX looks set to open flat this morning. It’s been reported that US and China are planning on delaying the next round of tariffs set for Sunday. The Flight Centre Travel Group (ASX:FLT) has expanded its global leadership team to increase the focus on leisure and corporate travel growth.
11 Dec 2019 - AMP (ASX:AMP) has announced some changes to the board with the appointment of Rahoul Chowdry as a Non-Executive Director.
11 Dec 2019 - Sustainable aquaculture company Seafarms Group (ASX:SFG) has reached its first community development milestone at Native Title holders’ upgrade of the Legune Station.
10 Dec 2019 - It has been a rollercoaster day of trade for the ASX. The local bourse managed to close 0.3% lower. Companies to lose the most ground were Avita Medical (ASX:AVH), Metcash (ASX:MTS) and Perenti Global (ASX:PRN). Cochlear (ASX:COH) today announced the appointment of Michael Daniell to the board - former Managing Director and CEO of Fisher & Paykel Healthcare Corporation.
10 Dec 2019 - The ASX has been on a bit of a rollercoaster ride this morning and is now riding flat at just 0.01% lower at noon. Shares in The A2 Milk company (ASX:A2M) rose today after yesterday’s news that CEO Jayne Hrdlicka is set to leave. Shares on the decline are the Lendlease Group (ASX:LLC), and Avita Medical (ASX:AVH). Midway (ASX:MWY) has successfully negotiated its first export price contract.
10 Dec 2019 - Global logistics solutions group, WiseTech Global (ASX:WTC) has bought Ready Korea, a customs solutions provider in South Korea.
10 Dec 2019 - Starpharma's (ASX:SPL) prostate cancer drug DEP cabazitaxel has successfully completed its phase one trials.
10 Dec 2019 - Centuria Metropolitan REIT (ASX:CMA) has acquired the NewActon Nishi Building commercial office property in Canberra for $256 million.
